Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites

Oncogene volume 30, pages 4731–4739 (2011)Cite this article

Subjects

Abstract

We have previously reported that the expression of antioxidative stress enzymes is upregulated by trans-hydroxytamoxifen (TOT) in breast epithelial cell lines providing protection against estrogen-induced DNA damage. This regulation involves Estrogen Receptor β (ERβ) recruitment to the Electrophile Response Element (EpRE) and a novel protein, human homolog of Xenopus gene which Prevents Mitotic Catastrophe (hPMC2). We have also demonstrated that ERβ and hPMC2 are required for TOT-dependent recruitment of poly (ADP-ribose) polymerase 1 (PARP-1) and Topoisomerase IIβ (Topo IIβ) to the EpRE. Sequence analysis reveals that the C-terminus of hPMC2 encodes a putative exonuclease domain. Using in vitro kinetic assays, we found that hPMC2 is a 3′–5′ non-processive exonuclease that degrades both single-stranded and double-stranded substrates. Mutation of two conserved carboxylate residues drastically reduced the exonuclease activity of hPMC2, indicating the relative importance of the catalytic residues. Western blot analysis of breast cancer cell lines for Quinone Reductase (QR) levels revealed that the intrinsic exonuclease activity of hPMC2 was required for TOT-induced QR upregulation. Chromatin immunoprecipitation (ChIP) assays also indicated that hPMC2 was involved in the formation of strand breaks observed with TOT treatment and is specific for the EpRE-containing region of the QR gene. We also determined that the transcription factor NF-E2-related factor-2 (Nrf2) is involved in the specificity of hPMC2 for the EpRE. In addition, we determined that the catalytic activity of hPMC2 is required for repair of abasic sites that result from estrogen-induced DNA damage. Thus, our study provides a mechanistic basis for transcriptional regulation by hPMC2 and provides novel insights into its role in cancer prevention.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Abbreviations

E2:

17-β estradiol

EpRE:

electrophile response element

ERE:

estrogen response element

ERβ:

estrogen receptor β

hPMC2:

human homolog of Xenopus gene which prevents mitotic catastrophe

QR:

quinone reductase

TOT:

trans-hydroxytamoxifen

References

  • Ando K, Hirao S, Kabe Y, Ogura Y, Sato I, Yamaguchi Y et al. (2008). A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNA-binding activity. Nucleic Acids Res 36: 4327–4336.

    Article  CAS  Google Scholar 

  • Berdis AJ . (2001). Dynamics of translesion DNA synthesis catalyzed by the bacteriophage T4 exonuclease-deficient DNA polymerase. Biochemistry 40: 7180–7191.

    Article  CAS  Google Scholar 

  • Bianco NR, Perry G, Smith MA, Templeton DJ, Montano MM . (2003). Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage. Mol Endocrinol 17: 1344–1355.

    Article  CAS  Google Scholar 

  • Bolton JL, Thatcher GR . (2008). Potential mechanisms of estrogen quinone carcinogenesis. Chem Res Toxicol 21: 93–101.

    Article  Google Scholar 

  • Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R et al. (2006). Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 1766: 63–78.

    CAS  PubMed  Google Scholar 

  • Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM et al. (1998). Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90: 1371–1388.

    Article  CAS  Google Scholar 

  • Gaikwad NW, Rogan EG, Cavalieri EL . (2007). Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic Biol Med 43: 1289–1298.

    Article  CAS  Google Scholar 

  • Hopp TA, Weiss HL, Parra IS, Cui Y, Osborne CK, Fuqua SA . (2004). Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 10: 7490–7499.

    Article  CAS  Google Scholar 

  • Hoss M, Robins P, Naven TJ, Pappin DJ, Sgouros J, Lindahl T . (1999). A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. EMBO J 18: 3868–3875.

    Article  CAS  Google Scholar 

  • Hsieh JC, Zinnen S, Modrich P . (1993). Kinetic mechanism of the DNA-dependent DNA polymerase activity of human immunodeficiency virus reverse transcriptase. J Biol Chem 268: 24607–24613.

    CAS  PubMed  Google Scholar 

  • Huang P . (1998). Excision of mismatched nucleotides from DNA: a potential mechanism for enhancing DNA replication fidelity by the wild-type p53 protein. Oncogene 17: 261–270.

    Article  CAS  Google Scholar 

  • Jordan VC . (1998). Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow. J Natl Cancer Inst 90: 967–971.

    Article  CAS  Google Scholar 

  • Ju BG, Lunyak VV, Perissi V, Garcia-Bassets I, Rose DW, Glass CK et al. (2006). A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 312: 1798–1802.

    Article  CAS  Google Scholar 

  • Liehr JG . (2000). Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21: 40–54.

    CAS  Google Scholar 

  • Marti TM, Fleck O . (2004). DNA repair nucleases. Cell Mol Life Sci 61: 336–354.

    Article  CAS  Google Scholar 

  • Mol CD, Izumi T, Mitra S, Tainer JA . (2000). DNA-bound structures and mutants reveal abasic DNA binding by APE1 and DNA repair coordination (corrected). Nature 403: 451–456.

    Article  CAS  Google Scholar 

  • Montano MM, Chaplin LJ, Deng H, Mesia-Vela S, Gaikwad N, Zahid M et al. (2007). Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis. Oncogene 26: 3587–3590.

    Article  CAS  Google Scholar 

  • Montano MM, Deng H, Liu M, Sun X, Singal R . (2004). Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications. Oncogene 23: 2442–2453.

    Article  CAS  Google Scholar 

  • Montano MM, Jaiswal AK, Katzenellenbogen BS . (1998). Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta. J Biol Chem 273: 25443–25449.

    Article  CAS  Google Scholar 

  • Montano MM, Katzenellenbogen BS . (1997). The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci USA 94: 2581–2586.

    Article  CAS  Google Scholar 

  • Montano MM, Wittmann BM, Bianco NR . (2000). Identification and characterization of a novel factor that regulates quinone reductase gene transcriptional activity. J Biol Chem 275: 34306–34313.

    Article  CAS  Google Scholar 

  • Moser MJ, Holley WR, Chatterjee A, Mian IS . (1997). The proofreading domain of Escherichia coli DNA polymerase I and other DNA and/or RNA exonuclease domains. Nucleic Acids Res 25: 5110–5118.

    Article  CAS  Google Scholar 

  • Nakamura T, Kuroda Y, Yamashita S, Zhang X, Miyamoto O, Tamiya T et al. (2008). Edaravone attenuates brain edema and neurologic deficits in a rat model of acute intracerebral hemorrhage. Stroke 39: 463–469.

    Article  CAS  Google Scholar 

  • Nakopoulou L, Lazaris AC, Panayotopoulou EG, Giannopoulou I, Givalos N, Markaki S et al. (2004). The favourable prognostic value of oestrogen receptor beta immunohistochemical expression in breast cancer. J Clin Pathol 57: 523–528.

    Article  CAS  Google Scholar 

  • Nguyen LH, Espert L, Mechti N, Wilson III DM . (2001). The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro. Biochemistry 40: 7174–7179.

    Article  CAS  Google Scholar 

  • Nioi P, McMahon M, Itoh K, Yamamoto M, Hayes JD . (2003). Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem J 374: 337–348.

    Article  CAS  Google Scholar 

  • Osborne CK, Wakeling A, Nicholson RI . (2004). Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. Br J Cancer 90 (Suppl 1): S2–S6.

    Article  CAS  Google Scholar 

  • Saji S, Hirose M, Toi M . (2005). Clinical significance of estrogen receptor beta in breast cancer. Cancer Chemother Pharmacol 56 (Suppl 1): 21–26.

    Article  Google Scholar 

  • Skalski V, Lin ZY, Choi BY, Brown KR . (2000). Substrate specificity of the p53-associated 3′-5′ exonuclease. Oncogene 19: 3321–3329.

    Article  CAS  Google Scholar 

  • Sripathy SP, Chaplin LJ, Gaikwad NW, Rogan EG, Montano MM . (2008). hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen. Oncogene 27: 6376–6384.

    Article  CAS  Google Scholar 

  • Wilson III DM, Takeshita M, Grollman AP, Demple B . (1995). Incision activity of human apurinic endonuclease (Ape) at abasic site analogs in DNA. J Biol Chem 270: 16002–16007.

    Article  CAS  Google Scholar 

  • Xanthoudakis S, Miao G, Wang F, Pan YC, Curran T . (1992). Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 11: 3323–3335.

    Article  CAS  Google Scholar 

  • Yager JD, Davidson NE . (2006). Estrogen carcinogenesis in breast cancer. N Engl J Med 354: 270–282.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Department of Defense Breast Cancer Postdoctoral award (BC087610) to NK and NIH Grant (CA92240) to MMM.

Author information

Authors and Affiliations

  1. Department of Pharmacology, Case Western Reserve University, Cleveland, OH, USA

    N Krishnamurthy, C R Ngam, A J Berdis & M M Montano

Authors
  1. N Krishnamurthy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C R Ngam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A J Berdis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M M Montano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M M Montano.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krishnamurthy, N., Ngam, C., Berdis, A. et al. The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites. Oncogene 30, 4731–4739 (2011). https://doi.org/10.1038/onc.2011.186

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2011.186

Keywords

This article is cited by

Search

Advanced search

Quick links